Peripheral Neuropathy Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed with a condition called CIDP (a nerve disorder), confirmed by a neurologist, with no record suggesting that diagnosis was later ruled out
• People who have been actively using at least one CIDP treatment for three months or more, with no sign that they stopped the treatment before their last neurologist visit — treatments that count include immunoglobulin, certain corticosteroids (but not low-dose prednisone or equivalent at 10mg or less per day on its own), plasma exchange, efgartigimod alfa, azathioprine, mycophenolate mofetil, cyclosporine, rituximab, or methotrexate
• People who still have some ongoing physical impairment, disability, or neurological problems at the time of joining, based on a specific scoring scale used by the trial (confirm with trial site)
• People who have signed a consent form agreeing to take part

Who may not be able to join:

• People who are already taking part in another clinical trial that involves an investigational (unapproved) drug at the time of joining
• People whose medical records show overactive reflexes during a neurological exam in the year before joining, recorded after their CIDP diagnosis was made
• People who are under 18 years of age at the time of joining

Important: Always verify eligibility with the trial site directly before applying.